# Cyclophosphamide

NDC: 69097-516
Generic name: Cyclophosphamide
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20190118

FDA application: ANDA211608

## Active ingredients

- CYCLOPHOSPHAMIDE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-516"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-516
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e1cb955-99c8-4fe5-89d1-399c8e52174e